Lijuan Yu, Xuehua Yang, Lu Xia, Jie Zhong, Wensong Ge, Jianxin Wu, . . . Zhanju Liu. (2015). Infliximab Preferentially Induces Clinical Remission and Mucosal Healing in Short Course Crohn's Disease with Luminal Lesions through Balancing Abnormal Immune Response in Gut Mucosa. Hindawi Limited.
Chicago Style (17th ed.) CitationLijuan Yu, Xuehua Yang, Lu Xia, Jie Zhong, Wensong Ge, Jianxin Wu, Hongchun Liu, Fei Liu, and Zhanju Liu. Infliximab Preferentially Induces Clinical Remission and Mucosal Healing in Short Course Crohn's Disease with Luminal Lesions Through Balancing Abnormal Immune Response in Gut Mucosa. Hindawi Limited, 2015.
MLA (9th ed.) CitationLijuan Yu, et al. Infliximab Preferentially Induces Clinical Remission and Mucosal Healing in Short Course Crohn's Disease with Luminal Lesions Through Balancing Abnormal Immune Response in Gut Mucosa. Hindawi Limited, 2015.